Cargando…
Effects of Photodynamic Therapy with Redaporfin on Tumor Oxygenation and Blood Flow in a Lung Cancer Mouse Model
Three photodynamic therapy (PDT) protocols with 15 min, 3 h and 72 h drug-to-light time intervals (DLIs) were performed using a bacteriochlorin named redaporfin, as a photosensitizer. Blood flow and pO(2) changes after applying these protocols were investigated in a Lewis lung carcinoma (LLC) mouse...
Autores principales: | Karwicka, Malwina, Pucelik, Barbara, Gonet, Michał, Elas, Martyna, Dąbrowski, Janusz M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718604/ https://www.ncbi.nlm.nih.gov/pubmed/31477749 http://dx.doi.org/10.1038/s41598-019-49064-6 |
Ejemplares similares
-
Intravenous Single-Dose Toxicity of Redaporfin-Based Photodynamic Therapy in Rodents
por: Rocha, Luis B., et al.
Publicado: (2015) -
Immune Responses after Vascular Photodynamic Therapy with Redaporfin
por: S. Lobo, Ana Catarina, et al.
Publicado: (2019) -
Treatment of Head and Neck Cancer with Photodynamic Therapy with Redaporfin: A Clinical Case Report
por: Santos, Lúcio Lara, et al.
Publicado: (2018) -
Photodynamic inactivation (PDI) as a promising alternative to current pharmaceuticals for the treatment of resistant microorganisms
por: Pucelik, Barbara, et al.
Publicado: (2022) -
Merging Preclinical EPR Tomography with other Imaging Techniques
por: Gonet, Michal, et al.
Publicado: (2019)